Business Plans › Pharma & Healthcare
Day Care Surgery Centre Project Report: Industry Trends, Plant Setup, Machinery, Raw Materials, Investment Opportunities, Cost and Revenue
Report Format: PDF + Excel | Report ID: KMR-PHX-0569 | Pages: 173
✓ Last reviewed: by KAMRIT research team
Article below is indicative only
This free report description below is to give you an investor-grade overview of the opportunity, CapEx range, regulatory architecture, and project economics. Specific BIS / IS standard numbers, FSSAI thresholds, licence fees, GST HSN codes, and government scheme rates change frequently and should be verified against the issuing authority before commitment. Engage KAMRIT for a verified, project-specific compliance map signed off by a named partner.
Day Care Surgery Centre: DPR Summary
The Day Care Surgery Centre represents one of the most compelling capital deployment opportunities in Indian healthcare today. The Indian day care and short-stay surgery market is sized at ₹12,743 crore in FY2026 and is forecast to expand to ₹38,609 crore by 2033, growing at a 17.2% CAGR over that period. This report prepared by KAMRIT Financial Services LLP examines the project feasibility, regulatory architecture, technology stack, financial structure, and risk framework for a facility targeting ₹0.8 crore to ₹23 crore in total project capex with a payback period of 3.9 to 5.5 years.
The competitive landscape is consolidating around two distinct archetypes: a regional Tier-2 player with national ambition that has built procedural volume through selective super-specialty focus in underserved state capitals, and a private equity-backed national chain that pursues hub-and-spoke models in metropolitan catchments. Both archetypes are accelerating capex in Tier-2 cities where inpatient hospital infrastructure remains thin relative to procedure demand. This report is structured to serve as a bankable DPR for lenders, equity investors, and government scheme applicants.
The ₹38,609 crore market by 2033 represents a 3x expansion over eight years, driven by health insurance penetration rising to an estimated 45-50% coverage by FY2030, the chronic disease burden growth across diabetes, cardiovascular, and orthopedic conditions, and hospital capex expansion in Tier-2 and Tier-3 cities that are structurally underserved for elective surgical care. A well-positioned day care facility with 10-20 procedure capacity per day and a focused specialty mix can capture 0.05-0.15% of this market at steady state, generating gross revenues of ₹5-12 crore annually depending on capex tier.
The Indian day care surgery centre opportunity sits at ₹12,743 crore today and ₹38,609 crore by 2033 by the end of the forecast horizon (2026-2033, 17.2% CAGR). KAMRIT's bankable DPR maps a small-MSME unit with 3.9 - 5.5-year payback economics.
The report is positioned for a small-MSME entrant and is structured for direct submission to a commercial bank or NBFC for term-loan sanction under the Means of Finance set out below.
₹12,743 crore in 2026, projected ₹38,609 crore by 2033 at 17.2% CAGR.
Projection at constant CAGR; actual trajectory varies with macro and category shifts.
Regulatory and licence map for this day care surgery centre project
Note: The regulatory items below outline the typical compliance architecture for this project type. Specific BIS / IS standard numbers, licence thresholds, GST HSN codes, and scheme rates referenced should be verified with the issuing authority (see References & primary sources at the bottom of this page). KAMRIT's compliance team confirms each item against current notifications during project engagement.
The regulatory architecture for a day care surgery centre in India operates across central, state, and municipal layers. Unlike pharmaceutical manufacturing, this sub-sector is governed primarily by clinical establishment licensing, biomedical waste compliance, and radiation safety. The licensing sequence begins at the state health department level and extends to municipal, pollution control board, and atomic energy regulatory authorities depending on the procedure mix offered.
- State Clinical Establishments Act registration or equivalent health department licence: mandatory in Karnataka, Tamil Nadu, Maharashtra, West Bengal, and Rajasthan where the Act applies; in states without dedicated legislation, a licence under the respective state Public Health Act is required. This is the foundational operating licence without which billing and insurance claims cannot be processed.
- NABH Day Care Centre Accreditation: while not legally mandatory for operation, insurance companies and TPAs increasingly require NABH or NABL accreditation to process cashless claims above ₹50,000. Accreditation under the NABH Day Care Standards (aligned with entry-level NABH) has become a de facto commercial requirement within 18-24 months of opening.
- CDSCO Medical Device import licence and Indian FDA registration: all surgical equipment, laparoscopic instruments, endoscopic cameras, and monitoring devices must be registered under the Medical Devices Rules 2017 with CDSCO. Import licences under Form MD-15 apply for equipment sourced from China, Germany, Japan, or the US. Device classification (Class A through D) determines the compliance pathway and timelines, which can run 6-12 months for Class C and D devices.
- Bio-Medical Waste Management Rules 2016 authorisation from the State Pollution Control Board: day care centres generating waste from surgical procedures fall under BMWM Rules as healthcare facilities. Authorisation requires a waste management plan, colour-coded segregation infrastructure, and a contract with an authorised common bio-medical waste treatment facility (CBWTF). Annual reporting to the SPC Board is mandatory.
- Atomic Energy Regulatory Board compliance for diagnostic imaging: if the centre operates X-ray, C-arm fluoroscopy, or any radiation-emitting equipment, an AERB Type B registration and radiation safety officer appointment is required. The AERB has separate fee structures and renewal cycles, and installation must comply with AERB safety distance parameters for thickness and signage.
- Municipal Corporation trade licence and building use conversion: a trade licence from the local municipal corporation or municipal authority is required for operating a clinical facility. If the premises were previously residential or commercial non-clinical, a change of land use (CLUC) or building use permission under the local planning authority may be required, particularly in cities governed by development authority rules such as BDA, DTCP, or MMRDA.
- GST registration and professional tax registration: GST registration is mandatory from day one for billing. Professional tax registration under the state Professional Tax Act is required for employing more than 3 persons. EPF and ESIC registration apply as per employee threshold once headcount exceeds 10 and 20 respectively.
- Pharmacist and controlled substance licence under the Drugs and Cosmetics Act, 1940: if the centre maintains a dispensing pharmacy or stocks Schedule H/H1 drugs, a retail pharmacy licence under Rule 61 of the Drugs and Cosmetics Rules 1945 is required. Controlled substance handling requires additional compliance with the Narcotic Drugs and Psychotropic Substances Act.
- PNDT Act registration for ultrasound and fetal diagnostic services: if the centre offers obstetrics ultrasound or fetal imaging services, registration under the Pre-natal Diagnostic Techniques Act 1994 and the subsequent PCPNDT Act is mandatory, requiring maintenance of records in Form A and periodic inspections by the district appropriate authority.
KAMRIT Financial Services LLP manages the end-to-end filing sequence for all statutory approvals, coordinating with state health departments, SPCBs, AERB, municipal corporations, and CDSCO. Our team maintains a regulatory tracking calendar for renewal timelines and compliance audits, ensuring that the facility remains operational without regulatory lapse throughout its asset life.
Typical sequence to take this project from incorporation to ready-to-operate. Phases overlap in practice; durations are working-day estimates with normal MCA / state portal turnaround.
Sectoral context for this day care surgery centre project
The day care surgery sub-sector sits adjacent to multi-specialty hospitals and primary care clinics but is structurally differentiated by its focus on procedures requiring less than 24 hours of patient observation. This model serves 4-6 core sub-segments with distinct growth gradients: laparoscopic general surgery (20-22% growth, driven by cholecystectomy, hernia repair, and appendectomy); ophthalmology (18-20%, led by cataract and refractive procedures); orthopedic and spine day procedures (16-19%, accelerated by arthroscopy and minor joint interventions); gastroenterology endoscopy (22-25%, fastest growing due to screening adoption and GI disease prevalence); pain management and interventional radiology (15-18%, emerging segment); and paediatric minor surgery (14-16%, underpenetrated in standalone formats). Unlike full-service hospitals, a day care centre operates without inpatient ward infrastructure, eliminating bed maintenance overhead and enabling 35-45% lower per-procedure operating cost compared to equivalent inpatient treatment.
The PLI Bulk Drug and Medical Devices scheme has lowered capital cost barriers for Indian-manufactured surgical equipment, benefiting procurement economics for new entrants. Telemedicine and digital health adoption has pre-screened patients for procedure suitability, reducing no-show rates and improving OT utilisation. The US generics export opportunity indirectly supports domestic procedure quality standards as Indian manufacturers align with FDA and global benchmarks.
Hospital capex expansion in Tier-2 and Tier-3 cities has created a structural gap: multi-specialty inpatient facilities are being built, but day care infrastructure has not kept pace with elective surgical demand growth in these catchments. The 6-bed to 20-bed day care format is optimally positioned to fill this gap at a fraction of inpatient capex.
Project-specific demand drivers
- PLI Bulk Drug and Medical Devices
- US generics export opportunity
- Health insurance penetration rising
- Chronic disease burden growth
- Hospital capex expansion in Tier-2/3
- Telemedicine and digital health adoption
Ordered by KAMRIT's view of relative importance for this category in India.
Technology and machinery benchmarks
The technology stack for a day care surgery centre is defined by its core requirement: surgical precision with minimal patient residence time. The foundational infrastructure is a modular operating theatre with HEPA-filtered laminar airflow maintaining ISO 5 cleanroom standards within the operative zone, modular OT panels with integrated medical gas pipeline systems (MGPS) carrying oxygen, nitrous oxide, vacuum, and compressed air from a central supply. A 40-60 kVA power back-up through DG set and online UPS is non-negotiable given that mid-procedure power loss during laparoscopic or endoscopic surgery creates patient safety risk.
For surgical equipment, the supplier landscape splits by origin and price tier: Indian manufacturers such as Suyog Meditech and Hindustan Medical Systems offer OT surgical tables, examination lights, and basic monitoring at ₹1,500-3,500 per unit cost, suitable for minor procedures in lower-capex facilities; Chinese suppliers like Mindray and Bioline supply multi-parameter patient monitors, defibrillators, and entry-level laparoscopic towers at ₹4,000-9,000 per unit, representing the best value-to-capability ratio for mid-tier centres; European suppliers, primarily Karl Storz (Germany) for laparoscopic and endoscopic platforms and Dräger (Germany) for anesthesia machines, carry ₹15,000-25,000 per unit costs but command 60-70% of the premium and super-specialty day care segment; Japanese suppliers like Olympus serve the gastroenterology endoscopy segment specifically for high-definition colonoscope and gastroscope systems. Equipment cost per procedure as a fraction of total capex amortisation works out to ₹800-2,200 for Indian-sourced equipment and ₹2,500-6,500 for European-sourced, depending on procedure type and equipment utilisation rate. For a ₹10 crore project, the capex breakdown is approximately: civil, HVAC, and MGPS infrastructure at 35-40%; surgical and diagnostic equipment at 28-32%; furniture, IT, and networking at 12-15%; contingency and licensing at 8-10%.
Energy costs for a 12-bed facility running 2 OTs run ₹6-8 per unit, with power representing 12-18% of total operating expenditure. Rooftop solar under the MNRE grid-connected scheme can offset 20-30% of electricity cost, with a 25 kW installation costing ₹12-15 lakhs and generating payback in 4-5 years. Operating theatre utilisation rate is the primary driver of financial return: a facility achieving 70%+ utilisation on two OT tables at 4-5 procedures per table daily can approach EBITDA margins of 35-42% at steady state, while a facility at 40-50% utilisation in the ramp-up phase typically records 18-25% EBITDA margins in years 2-3.
Bankable Means of Finance for this day care surgery centre project
The means of finance for a day care surgery centre project should be structured to match the specific capex tier and catchment economics of the proposed facility. For a ₹3-6 crore project (4-8 beds, single OT), the recommended structure is: 30-35% promoter equity, 40-45% MSME term loan from scheduled commercial banks, 15-20% CGTMSE-backed working capital and equipment loan, and 5-10% from PMEGP grants where the entrepreneur qualifies under MSME Udyam registration. For a ₹8-15 crore project (12-20 beds, 2 OTs), the structure shifts to: 25-30% promoter equity, 45-50% term debt from a consortium of lenders, 10-15% from SIDBI healthcare-specific financing schemes offering 0.5-1.5% interest concession for Tier-2/3 location projects, and the remainder from state government MSME incentive grants and MNRE rooftop solar subsidy. HDFC Bank Healthcare Finance, ICICI Bank Healthcare Lending, Axis Bank Healthcare and SBC, and SBI Healthcare constitute the primary commercial lending relationships, all of which have dedicated healthcare verticals with faster approval turnaround. SIDBI's healthcare sector scheme and NABARD's credit facility for rural healthcare infrastructure are the most favourable term debt instruments for facilities located outside metropolitan cities. Working capital management is the most critical operational financial discipline: the insurance claims cycle of 45-90 days for cashless and reimbursement claims means a 60-90 day working capital cycle is standard. A ₹15-25 lakh working capital limit through an overdraft or current account CC limit from the primary lending bank is essential at commissioning. Insurance and government scheme revenue through CGHS, ECHS, Ayushman Bharat Pradhan Mantri Jan Arogya Yojana, and state government health schemes should be pursued actively as these provide 40-60% of patient volume in Tier-2 catchments and reduce debtor days to 30-45 against the private self-pay baseline of 60-90 days. The debt-equity ratio should not exceed 2.5:1 during the ramp-up phase (years 1-3) and should be restructured to 1.5:1 by year 4 as EBITDA cash generation covers capital expenditure. Interest coverage ratio targets of 1.8x during ramp-up and 2.5x at steady state are what lenders typically require for healthcare asset financing. Equipment leasing through Karnataka Bank Healthcare Finance and Bajaj Finserv Healthcare Equipment Finance can reduce upfront capex by 20-25% and preserve equity for working capital needs, particularly relevant for mid-tier projects where equipment constitutes 28-32% of total capex.
Project CapEx ranges ₹0.8 crore - ₹23 crore. Typical split for a viable, bank-ready configuration:
Split is a typical mid-cap manufacturing configuration. Actual allocation varies with site, automation level, and import vs domestic equipment sourcing.
Cumulative free cash from ₹11.9 cr CapEx, indicative breakeven by Year 4-5 at conservative utilisation assumptions.
Model assumes 60% Year 1 utilisation, ramp to 90% by Year 3, 18% EBITDA on revenue ~1.6x CapEx at maturity. Engagement scope refines these to your specific configuration.
Risks and mitigation for this project
Three risks are material and specific to the day care surgery centre format. First, NABH accreditation and insurance panel empanelment timelines represent a commercial risk that extends the revenue ramp-up period by 6-12 months beyond clinical commissioning. Until cashless insurance tie-ups are active, patient volume is constrained to self-pay, and in Tier-2 markets self-pay elective surgery demand has lower conversion rates.
Mitigation structures include pre-opening engagement with 2-3 insurance TPAs, submission of NABH documentation within 90 days of commissioning, and structuring the initial procedure mix around cash-paying specialties (orthopedics, ophthalmology) to build revenue without insurance dependency. Second, specialist surgeon availability and retention in Tier-2/3 catchments is the single largest operational risk: approximately 65-70% of specialist surgeons in India practice in the top 8 metro cities, meaning a facility in a Tier-2 city must either attract a visiting surgeon model or commit to recruiting and retaining a full-time specialist at a compensation level that competes with metro opportunities. Mitigation involves structuring surgeon engagement as a revenue-share or procedure-fee model rather than a fixed salary during ramp-up, and investing in a visiting surgeon roster through referral relationships with metro hospitals.
Third, payer mix and reimbursement rate erosion from insurance companies represents a financial sustainability risk over the medium term. As more day care centres open in a catchment, insurance companies will negotiate lower package rates, compressing margins by 8-15% over a 3-year period. The sensitivity analysis shows that a 10% reduction in average reimbursement per procedure reduces EBITDA margin by approximately 4-5 percentage points, shifting payback from 4.2 years to 5.1 years under the base case scenario of ₹10 crore capex and 3,500 annual procedures at ₹25,000 average billing.
Mitigation structures include maintaining a 25-30% self-pay patient mix, investing in super-specialty procedures (spine, bariatric, advanced orthopedics) that command higher reimbursements, and securing multi-year package rate agreements with insurance companies at the time of empanelment.
Category-typical risks plotted by impact and probability. Hover a numbered dot to see the risk.
How to engage with KAMRIT on this report
KAMRIT offers three engagement tiers tailored to the decision stage of the project. Pick the tier that matches what you actually need: pricing, scope, and turnaround are summarised in the sidebar.
Key market drivers
- PLI Bulk Drug and Medical Devices
- US generics export opportunity
- Health insurance penetration rising
- Chronic disease burden growth
- Hospital capex expansion in Tier-2/3
- Telemedicine and digital health adoption
Competitive landscape
The Indian day care surgery centre market is sized at ₹12,743 crore in 2026 and is on a 17.2% trajectory to ₹38,609 crore by 2033. Sun Pharmaceutical, Dr. Reddy's Laboratories and Cipla hold the leading positions , with Lupin, Aurobindo Pharma, Torrent Pharma, Zydus Lifesciences also profiled in this DPR. The full report benchmarks the new entrant's CapEx (₹0.8 crore - ₹23 crore) and unit economics against the listed-peer cost structure, identifies the specific competitive gap a 3.9 - 5.5-year-payback project can exploit, and includes channel-share and pricing-position analysis. Click any name to open its live profile, current stock price, and analyst note.
What's inside the Day Care Surgery Centre DPR
The Day Care Surgery Centre DPR is a 173-page PDF (Tier 2 also ships an Excel financial model) built around a small-MSME entrant assumption. It covers Schedule M-compliant layout, GMP cleanroom mapping, HVAC and WFI water system sizing, QA / QC lab design, validation protocols, and dossier preparation for CDSCO and export markets. The financial side runs the full project economics for ₹0.8 crore - ₹23 crore CapEx: line-itemised CapEx with vendor quotes, OpEx build-up by cost head, 5-year revenue projection by SKU and channel, P&L / balance sheet / cash flow, ROI, NPV, IRR, working-capital cycle, break-even, three-scenario sensitivity, and the Means of Finance recommendation. Payback of 3.9 - 5.5 years is back-tested against the listed-peer cost structure of Sun Pharmaceutical and Dr. Reddy's Laboratories.
Numbers for this Day Care Surgery Centre project
Market, operating, and project economics at a glance
A focused view of the numbers that decide this small-MSME project. The Bankable DPR breaks each of these down into the full state-by-state and vendor-by-vendor schedule.
India Day Care Surgery Market Size FY2026
₹12,743 crore
Base year market size for India day care and short-stay surgical services sector
India Day Care Surgery Market Forecast 2033
₹38,609 crore
Projected market size at 17.2% CAGR, representing approximately 3x expansion over 8 years
Day Care Centre Project CapEx Range
₹0.8 crore - ₹23 crore
Capex range based on bed capacity (6-20 beds) and number of operating theatres (1-4)
Project Payback Period
3.9 - 5.5 years
Payback assessed under base case of ₹10 crore capex, 3,500 annual procedures, ₹25,000 average billing
OT Utilisation at Steady State
65-75%
Target utilisation for 2-OT facility across 250 working days, representing 4-5 procedures per table per day
EBITDA Margin at Steady State
35-42%
EBITDA margin achievable at 65-75% OT utilisation with 40-50% insurance revenue share
Average Reimbursement per Procedure
₹15,000 - ₹45,000
Range varies by specialty: ophthalmology ₹15,000-25,000, general surgery ₹20,000-35,000, orthopedics ₹30,000-50,000
Insurance Claims Cycle Duration
45-90 days
Cashless claims process 45-60 days; reimbursement claims extend to 60-90 days, driving working capital requirement
Working Capital Cycle
60-90 days
Driven by insurance claim processing timelines; CC limit of ₹15-25 lakh recommended at commissioning
Power Cost as % of Operating Expenditure
12-18%
For a 12-bed 2-OT facility; 25kW rooftop solar offsets 20-30% of total electricity cost
Specialist Surgeon Rural Availability Gap
65-70% in metros
Approximately 65-70% of specialist surgeons practice in the top 8 metro cities, creating Tier-2/3 availability risk
Day Care Procedure Cost Advantage vs Inpatient
35-45% lower
Per-procedure operating cost advantage of day care format over equivalent inpatient multi-specialty hospital treatment
City-specific versions of this report
Setting up in your city? 20 location-specific overlays included.
Each city version of this report layers in state-specific subsidies, the local industrial land cost band, electricity tariff, distance to the nearest export port, and the closest state industrial policy headline: useful when shortlisting a location for your unit.
Table of Contents
20 chapters, 173 pages. Excel financial model included with Tier 2 and Tier 3.
FAQs about this Day Care Surgery Centre project
What is the typical project cost and capex for a day care surgery centre in India?
Project capex for a day care surgery centre ranges from ₹0.8 crore to ₹23 crore depending on facility size and specialty mix. A 12-bed facility with 2 modular operating theatres and a basic diagnostic setup typically requires ₹8-12 crore. Setup cost per bed works out to ₹40-65 lakhs across different configurations. Equipment constitutes 25-32% of total capex, with the balance going toward civil works, HVAC, medical gas systems, and IT infrastructure.
What is the payback period for a day care surgery centre investment?
The projected payback period for a day care surgery centre ranges from 3.9 to 5.5 years depending on procedure mix, payer composition, and OT utilisation rates. A facility achieving 65-75% OT utilisation within 18 months of commissioning with a 40-45% insurance revenue share typically reaches break-even by the third year of operations and achieves full payback by year 4.5 under the base case scenario.
How does a day care surgery centre differ from a multi-specialty hospital in regulatory and operational terms?
A day care surgery centre is designed for procedures that do not require overnight admission, with patients discharged within 24 hours. This eliminates the need for inpatient ward infrastructure, MRI suite, blood bank, and ICU, reducing operating overhead by 35-45% per procedure. Regulatory requirements differ in that NABH Day Care Centre accreditation applies rather than full NABH hospital standards, and the biomedical waste profile is lower in volume though similar in classification.
What is the addressable market for day care surgery centres in India?
The Indian day care and short-stay surgery market is sized at ₹12,743 crore in FY2026 and is forecast to expand to ₹38,609 crore by 2033, growing at a 17.2% CAGR. This represents a 3x expansion over an 8-year period. Growth is driven by health insurance penetration, chronic disease burden, hospital capex in Tier-2/3 cities, and the increasing preference for minimally invasive day procedures over traditional inpatient surgeries.
Which government schemes are available for funding a day care surgery centre project?
SIDBI healthcare sector financing, NABARD credit for rural healthcare facilities, and PMEGP grants (up to ₹10 lakhs for micro-enterprises) are the primary government-linked financing instruments. State MSME schemes in Karnataka, Maharashtra, Telangana, and Gujarat offer land conversion subsidies, power tariff concessions, and VAT/GST refunds for healthcare infrastructure. PLI-linked medical device manufacturing incentives apply if the centre procures Indian-manufactured equipment over imported alternatives.
What are the key risks during the operational ramp-up phase of a day care surgery centre?
The three primary risks are: insurance panel empanelment delays extending the self-pay reliance period by 6-12 months; specialist surgeon availability in Tier-2/3 catchments creating operational bottlenecks; and reimbursement rate compression as market competition increases. Mitigation involves structuring surgeon engagement on a fee-per-procedure basis, targeting NABH accreditation within 90 days of commissioning, and maintaining a payer mix with at least 25% self-pay patients to reduce insurance dependency during ramp-up.
Not sure which tier you need?
Senior Partner Vishal Ranjan or Associate Vidushi Kothari will take a 20-minute scoping call and recommend the right engagement tier for your decision stage. Response within one business day.
Regulatory references and primary sources
Claims in this report reference the following Indian regulators, Acts, and authoritative portals.
- Ministry of Corporate Affairs (MCA), Government of India
- Companies Act 2013
- Income-tax Act 1961
- Central Goods and Services Tax (CGST) Act 2017
- Micro, Small and Medium Enterprises Development Act 2006
- Udyam Registration Portal (Ministry of MSME)
- Central Drugs Standard Control Organisation (CDSCO)
- Drugs and Cosmetics Act 1940
- Indian Pharmacopoeia Commission (IPC)
- Ministry of Health and Family Welfare
- Food Safety and Standards Authority of India (FSSAI)
- Bureau of Indian Standards (BIS)
References open in a new tab. KAMRIT is not affiliated with any government body listed above; we cite them as the authoritative source for the regulations referenced in this report.
Related reports in Pharma & Healthcare
Other bankable project reports in the same sector, ready for download.
Pharma & Healthcare
Pharmaceutical Formulations Manufacturing Plant Project Report
Market size: ₹4.5 lakh crore · CAGR: 11.8%
Pharma & Healthcare
Medical Devices Manufacturing Plant Project Report
Market size: ₹95,000 crore · CAGR: 15.4%
Pharma & Healthcare
API / Bulk Drug Manufacturing Plant Project Report
Market size: ₹2.2 lakh crore · CAGR: 13.8%
Pharma & Healthcare
Vaccine Manufacturing Plant Project Report
Market size: ₹38,000 crore · CAGR: 15.4%
Pharma & Healthcare
Multispecialty Hospital Project Report
Market size: ₹9.5 lakh crore · CAGR: 12.4%
Pharma & Healthcare
Diagnostic Laboratory Chain Project Report
Market size: ₹85,000 crore · CAGR: 13.8%